These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 10424369

  • 1. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model.
    Ao PY, Hawthorne WJ, Coombs R, Fletcher JP.
    Int Angiol; 1999 Jun; 18(2):131-9. PubMed ID: 10424369
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacological control of intimal hyperplasia in small diameter polytetrafluoroethylene grafts. An experimental study.
    Simoni G, Galleano R, Civalleri D, Decian F, Desalvo P, Ceppa P, Baccini P, Lenti E, Bachi V.
    Int Angiol; 1996 Mar; 15(1):50-6. PubMed ID: 8739537
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of fibro-intimal hyperplasia in a polytetrafluoroethylene vascular graft with standard heparin and low molecular weight heparin.
    Taylor A, Fletcher JP, Ao PY.
    Aust N Z J Surg; 1996 Nov; 66(11):764-7. PubMed ID: 8918386
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic and pharmacodynamic characterization of a medium-molecular-weight heparin in comparison with UFH and LMWH.
    Alban S, Welzel D, Hemker HC.
    Semin Thromb Hemost; 2002 Aug; 28(4):369-78. PubMed ID: 12244484
    [Abstract] [Full Text] [Related]

  • 11. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E, Lane DA, Ireland H, Flynn A, Curtis JR.
    Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [Abstract] [Full Text] [Related]

  • 15. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
    Grimaudo V, Omri A, Kruithof EK, Hauert J, Bachmann F.
    Thromb Haemost; 1988 Jun 16; 59(3):388-91. PubMed ID: 2847348
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coagulation effects of low molecular weight heparin compared with heparin in dogs considered to be at risk for clinically significant venous thrombosis.
    Scott KC, Hansen BD, DeFrancesco TC.
    J Vet Emerg Crit Care (San Antonio); 2009 Feb 16; 19(1):74-80. PubMed ID: 19691587
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 16; 423():1-336. PubMed ID: 12616288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.